PharVision Advisers’s Coursera COUR Stock Holding History

PharVision Advisers’s Portfolio COUR Stock Details COUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$68.1K	Sell	13,738 -790	-5%	-$4.44K	2.77%	14
2026 Q2	$81.9K	Buy	+14,528	New	+$82.5K	1.54%	31
2026 Q1	–	Sell	-33,353	Closed	-$245K	–	223
2025 Q4	$245K	Buy	33,353 +10,135	+44%	+$88.3K	0.12%	403
2025 Q3	$272K	Buy	+23,218	New	+$252K	0.15%	287
2025 Q2	–	Sell	-12,983	Closed	-$86.5K	–	297
2025 Q1	$86.5K	Buy	+12,983	New	+$103K	0.12%	254

Other funds holding COUR

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $627M AUM 18.86% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

S2L

Sparta 24 Ltd Tirat Hacarmel, Israel $90.5M AUM 17.81% 1-Year Est. Return

Hamilton Lane Advisors Conshohocken, Pennsylvania $179M AUM 25.1% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

PharVision Advisers's COUR Position: Q3 2026 in Review

PharVision Advisers reduced its Coursera (COUR) stake by 5.4% in Q3 2026, selling an estimated $4.44K and leaving 13,738 shares worth $68.1K. The position accounts for 2.77% of the portfolio, ranked #14.

PharVision Advisers first reported a position in COUR in Q1 2025 and has held it in 5 quarters since. The position peaked at $272K in Q3 2025. 67 funds tracked by Wall St. Rank hold COUR as of Q3 2026.

PharVision Advisers held 13,738 shares of Coursera worth $68.1K as of Q3 2026.
PharVision Advisers sold 790 Coursera shares in Q3 2026, an estimated $4.44K.
Coursera made up 2.77% of PharVision Advisers's portfolio in Q3 2026, its #14 holding.
PharVision Advisers first reported a position in Coursera in Q1 2025 and has held it in 5 quarters since.
PharVision Advisers's Coursera position peaked at $272K in Q3 2025.
67 funds tracked by Wall St. Rank held Coursera as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.